Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
B
Baalasubramanian, Sivasankar
Immunitas Bio
(
M0930-02-07
)
Low Blood Volume Alternative for Monitoring COVID-Specific T-Cell Immunity
Sivasankar Baalasubramanian
Favorite
Baijnath, Himansu
University of KwaZulu-Natal
(
M1430-01-01
)
Nanocapsules for Combined Delivery of Docetaxel and
Laguncularia Racemosa
Extract Against Oral Cancer Cells In Vitro
Himansu Baijnath
Favorite
Bai, Shuhua
Western New England University
(
T1030-01-02
)
Blueberry-Derived Exosomes as a Natural miRNA Delivery System for the Treatment of Neurodegenerative Diseases
Shuhua Bai
Favorite
Balas, E. Andrew
Augusta University
(
T1230-02-06
)
Fostering Innovation and Expanding Institutional Research from Bench to Bedside
E. Andrew Balas
Favorite
Balasubramanian, Nanda
Bristol-Myers Squibb Company
(
M1030-02-08
)
Simplifying Cellular Immunogenicity Monitoring for Novel Therapeutics through a sMHC-1 Immunopeptidomics Approach
Nanda Balasubramanian
Favorite
Balu-Iyer, Sathy
State University of New York at Buffalo, The
(
M1430-02-08
)
Structural Modifications of Phosphatidylserine and Their Impact on Oral Tolerance
Sathy Balu-Iyer
Favorite
Batni, Anjana
Immunitas Bio
(
M0930-02-07
)
Low Blood Volume Alternative for Monitoring COVID-Specific T-Cell Immunity
Anjana Batni
Favorite
Beck, Robert
BioAgilytix
(
M1330-02-09
)
Qualification of a Novel Multiplex Assay for the Quantitation of Chemokine Markers in Human Plasma and CSF Samples
Robert Beck
Favorite
Belanger, Justine
Cerba Research
(
T1130-02-07
)
Mitigation of the Presence of Crosstalk in an ADA Bridging Assay Using the MSD Platform for the Detection of Antibodies against an Antibody-Drug Conjugate
Justine Belanger
Favorite
Bengtson, Adam
Waters Corporation
(
M1030-01-01
)
Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Adam Bengtson
Favorite
Bhattacharya, Sanghati
University of Iowa
(
T1230-01-05
)
Impact of Excipient Composition on the Stability of Trastuzumab Biosimilars
Sanghati Bhattacharya
Favorite
Bhavsar, Gaurang
Micro Labs USA, Inc.
(
M1130-02-06
)
Anti-Urolithiatic and Diuretic Activities of Ethyl Acetate Fraction of
Grewia flavescens
Roots
Gaurang Bhavsar
Favorite
(
T1030-01-05
)
GCMS Analysis of Bioactive Compounds of Extracted Growth Hormone Concentration (Auxin) and Antimicrobial Activity of
Pentas
lanceolata and
Chrysanthemum
Morifolium: An Ornamental Flowering Plants
Gaurang Bhavsar
Favorite
Bhela, Siddheshvar
Genentech, Inc.
(
M1030-02-07
)
Pharmacokinetic/Pharmacodynamic Insights into VSIG4 Degrading Antibodies
Siddheshvar Bhela
Favorite
Bigwarfe, Tammy
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Tammy Bigwarfe
Favorite
Bittner, Beate
Roche
(
T1430-01-02
)
Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs
Beate Bittner
Favorite
Blanco, Veronica
Croda Inc.
(
M1130-02-09
)
Alternative Detergents to Triton X-100 for Disrupting Lipid Nanoparticles and Enhancing RNA Encapsulation Quantification in RiboGreen Assay
Veronica Blanco
Favorite
Box, Karl
Pion Inc.
(
M1130-02-08
)
Conserving Biorelevant Enzymatic Activity during In Vitro Analysis of Biotransformable Drugs
Karl Box
Favorite
Braham, Scott
Eurofins Viracor BioPharma Services
(
M1230-02-08
)
Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab
Scott Braham
Favorite
Braithwaite, Christian
BioAgilytix
(
M1330-02-09
)
Qualification of a Novel Multiplex Assay for the Quantitation of Chemokine Markers in Human Plasma and CSF Samples
Christian Braithwaite
Favorite
(
T1030-02-06
)
Qualification of the S-PLEX Neurology Panel 1 (GFAP, NfL and Tau) MSD Assay
Christian Braithwaite
Favorite
Bramhall, Jessica
University of Georgia
(
T1230-01-04
)
Application of Experimentally Derived Hansen Solubility Parameters to Optimize Amorphous Solid Dispersion Formulation
Jessica Bramhall
Favorite
Brandstetter, Dominik
Coriolis Pharma Research GmbH
(
M1230-01-02
)
Additivity of Transfer Free Energies Enables Description of Complex Protein Formulations in Implicit Solvent Molecular Dynamics Simulations
Dominik Brandstetter
Favorite
(
M1430-01-05
)
Running at the Verge of Collapse in Lyophilization: What is the Impact of the Edge Vial Effect on Protein Stability and Particle Morphology?
Dominik Brandstetter
Favorite
Buckley, Michael
University of Tennessee
(
M1430-01-03
)
Enhanced Membrane Composition for Lipid Nanoparticle Vascular Drug Delivery
Michael Buckley
Favorite
(
T1430-01-04
)
Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies
Michael Buckley
Favorite
Bui, Tam
Custom Biologics
(
T0930-02-08
)
Validation of an Anti-Drug Antibody Assay Against an Oncolytic Virus Immunotherapeutic
Tam Bui
Favorite
